Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study

Lawrence F. Eichenfield,J.Q. Del Rosso,Jerry Tan,Adelaide A. Hebert,Guy F. Webster,Julie C. Harper,Hilary E. Baldwin,Leon Kircik,Linda Stein Gold,A Kaoukhov,Nancy Alvandi

Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study

2019

Lawrence F. Eichenfield
J.Q. Del Rosso
Jerry Tan
Adelaide A. Hebert
Guy F. Webster
Julie C. Harper
Hilary E. Baldwin
Leon Kircik
Linda Stein Gold
A Kaoukhov
Nancy Alvandi

Background Once‐daily topical oxymetazoline cream 1·0% significantly reduced persistent facial erythema of rosacea in trials requiring live, static patient assessments.

Keywords:

Dermatology
Clinical trial
Oxymetazoline
Erythema
Medicine
Rosacea
in vehicle
once daily
alternative methods
facial skin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations